Research progress of individualized choice of treatment for early-stage primary hepatocellular carcinoma patients
10.3760/cma.j.cn113884-20241123-00341
- VernacularTitle:早期原发性肝细胞癌患者治疗方式的个体化选择研究进展
- Author:
Xuewei JIANG
1
;
Awang DANZENG
;
Xiaoyin YUAN
;
Ling GUO
;
Zhengwei HE
;
Zhenhua YANG
;
Hang WU
;
Binhao ZHANG
Author Information
1. 武汉科技大学附属天佑医院肝胆胰外科，武汉 430064
- Publication Type:Journal Article
- Keywords:
Carcinoma, hepatocellular;
Liver transplantation;
Liver resection;
Radiofrequency ablation;
Radiation therapy;
Individual
- From:
Chinese Journal of Hepatobiliary Surgery
2025;31(3):231-236
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is a prevalent malignant tumor that poses a significant threat to public health. Advances in medical science and increased screening awareness have improved early-stage diagnosis rates, allowing more patients to undergo radical treatment at initial diagnosis. Concurrently, ongoing developments in treatment modalities have expanded the options available for both patients and clinicians. The challenge now lies in making informed decisions to achieve individualized precision medicine, which merits thorough exploration. This article aims to review the latest research on personalized treatment strategies for early-stage HCC, providing a reasonable reference and valuable insights for clinicians.
